Zonggui Wang

Title: Innovations of Zonggui Wang in Pharmaceutical Science

Introduction

Zonggui Wang is a notable inventor based in Hefei, China. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative work on drug formulations. His research focuses on enhancing drug efficacy and safety, which is crucial in the development of new therapeutic agents.

Latest Patents

Zonggui Wang holds a patent for a "Memantine paroxetine cocrystal salt and its preparation method, pharmaceutical composition and application." This invention provides a cocrystal salt of memantine paroxetine sulfate hydrate. The mechanism of action involves being a 5-HT inhibitor and NMDA receptor antagonist, making it a multi-target drug. Preliminary pharmacokinetic experiments have shown that the cocrystal salt significantly improves drug absorption, blood drug concentration, bioavailability, and curative effect. This advancement offers a material basis for reducing dosage and adverse drug reactions, enhancing the therapeutic potential of the drug.

Career Highlights

Zonggui Wang is associated with Hefei Keda Bio-technology Co. Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug formulations and patient outcomes. The impact of his research is evident in the advancements made in drug delivery systems and therapeutic applications.

Collaborations

Zonggui Wang collaborates with talented individuals such as Ke Wang and Qianliu Cheng. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical innovations.

Conclusion

Zonggui Wang's contributions to pharmaceutical science through his innovative patent demonstrate his commitment to improving drug efficacy and safety. His work not only enhances therapeutic options but also paves the way for future advancements in the field.